Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer

BACKGROUND: At least 30% of patients with primary resectable non-small cell lung cancer (NSCLC) will experience a relapse in their disease within 5 years following definitive treatment. Clinicopathological predictors have proved to be suboptimal in identifying high-risk patients. We aimed to establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinato, D J, Shiner, R J, Seckl, M J, Stebbing, J, Sharma, R, Mauri, F A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992503/
https://www.ncbi.nlm.nih.gov/pubmed/24667648
http://dx.doi.org/10.1038/bjc.2014.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992503/
https://www.ncbi.nlm.nih.gov/pubmed/24667648
http://dx.doi.org/10.1038/bjc.2014.145

Ejemplares similares